Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 1402 to 1451 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1402\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.15625\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.640129\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.244091425\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FBXO28\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1403\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EUKARYOTIC TRANSLATION INITIATION FACTOR 2 SUBUNIT 2 (EUKARYOTIC TRANSLATION INITIATION FACTOR 2 BETA SUBUNIT) (EIF-2-BETA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.291311\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.19358\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.244064914\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EIF2S2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1404\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EPSIN 3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0468234\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.191876\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.244029477\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EPN3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1405\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FRAGILE X MENTAL RETARDATION 1 PROTEIN (PROTEIN FMR-1) (FMRP). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.354424\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.45239\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.244028119\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FMR1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1406\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYTOCHROME C. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0314533\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.128904\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.244005617\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
CYCS\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1407\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HEPARAN SULFATE 6-O-SULFOTRANSFERASE; HEPARAN-SULFATE 6-SULFOTRANSFERASE. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
HS6ST1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1408\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WW DOMAIN BINDING PROTEIN 11; NPW38-BINDING PROTEIN NPWBP; SH3 DOMAIN-BINDING PROTEIN SNP70. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0575359\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.235798\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.244005038\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
WBP11\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1409\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELAC HOMOLOG 2; PUTATIVE PROSTATE CANCER SUSCEPTIBILITY PROTEIN; ELAC (E. COLI) HOMOLOG 2. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
ELAC2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1410\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HEPARAN SULFATE 6-O-SULFOTRANSFERASE 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0260119\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.106604\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.244004915\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HS6ST2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1411\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RNA-BINDING PROTEIN 10 (RNA BINDING MOTIF PROTEIN 10) (DXS8237E). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0900822\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.369182\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.244004854\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RBM10\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1412\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RNA-BINDING PROTEIN 5 (RNA BINDING MOTIF PROTEIN 5) (PUTATIVE TUMOR SUPPRESSOR LUCA15) (G15 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0739703\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.303151\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.244004803\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RBM5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1413\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.311796\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.27783\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.244004289\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PIH1D1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1414\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FATTY ACID HYDROXYLASE DOMAIN CONTAINING 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0263893\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.108151\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.244004216\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FA2H\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1415\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUCLEOPORIN NUP43 (P42). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.149203\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.611499\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243995493\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NUP43\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1416\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.651969\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.67215\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243986677\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NOL10\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1417\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FRAGILE X MENTAL RETARDATION SYNDROME RELATED PROTEIN 1. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.458713\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1.88011\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.243982001\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
FXR1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1418\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FRAGILE X MENTAL RETARDATION SYNDROME RELATED PROTEIN 2. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
FXR2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1419\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP-DEPENDENT RNA HELICASE DDX18 (DEAD-BOX PROTEIN 18) (MYC-REGULATED DEAD-BOX PROTEIN) (MRDB). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.858096\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.51778\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243931116\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DDX18\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1420\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"TRANSDUCIN BETA-LIKE 1X PROTEIN (TRANSDUCIN-BETA-LIKE 1, X-LINKED). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0306345\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.125605\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243895546\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TBL1X\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1421\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"TRANSDUCIN BETA-LIKE 1Y PROTEIN (TRANSDUCIN-BETA-LIKE 1, Y-LINKED). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0303893\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.1246\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243894864\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TBL1Y\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1422\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0315995\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.129562\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243894815\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PCID2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1423\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUCLEAR RECEPTOR CO-REPRESSOR/HDAC3 COMPLEX SUBUNIT TBLR1 (TBL1- RELATED PROTEIN 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.031639\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.129724\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.24389473\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1424\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IMPORTIN BETA-1 SUBUNIT (KARYOPHERIN BETA-1 SUBUNIT) (NUCLEAR FACTOR P97) (IMPORTIN 90). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.35972\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.4749\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243894501\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KPNB1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1425\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.352259\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.44441\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243877431\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DCLK2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1426\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MICROTUBULE-ASSOCIATED PROTEIN RP/EB FAMILY MEMBER 1 (APC-BINDING PROTEIN EB1). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.109553\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.449228\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.243869483\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAPRE1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1427\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HISTIDINE-RICH MEMBRANE PROTEIN KE4. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
SLC39A7\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1428\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MICROTUBULE-ASSOCIATED PROTEIN RP/EB FAMILY MEMBER 3 (PROTEIN EB3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0890817\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.365289\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243866363\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAPRE3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1429\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"MICROTUBULE-ASSOCIATED PROTEIN, RP/EB FAMILY, MEMBER 2; T-CELL ACTIVATION PROTEIN, EB1 FAMILY; APC-BINDING PROTEIN EB1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0850122\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.348604\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243864672\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MAPRE2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1430\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTEASOME SUBUNIT ALPHA TYPE 1 (EC 3.4.25.1) (PROTEASOME COMPONENT C2) (MACROPAIN SUBUNIT C2) (MULTICATALYTIC ENDOPEPTIDASE COMPLEX SUBUNIT C2) (PROTEASOME NU CHAIN) (30 KDA PROSOMAL PROTEIN) (PROS-30). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.38784\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5.69292\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243783507\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PSMA1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1431\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ENTHOPROTIN; EPSIN 4; CLATHRIN INTERACTING PROTEIN LOCALIZED IN THE TRANS-GOLGI REGION. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.086609\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.355321\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.24374861\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1432\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINE/THREONINE-PROTEIN KINASE DCAMKL1 (EC 2.7.1.-) (DOUBLECORTIN- LIKE AND CAM KINASE-LIKE 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.408607\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.67671\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.24369569\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DCLK1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1433\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RNA HELICASE-RELATED PROTEIN; RNA HELICASE-LIKE PROTEIN; SF3B125 DEAD-BOX PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.038631\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.158546\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243657992\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1434\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPLICING FACTOR U2AF 35 KDA SUBUNIT (U2 AUXILIARY FACTOR 35 KDA SUBUNIT) (U2 SNRNP AUXILIARY FACTOR SMALL SUBUNIT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.116077\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.476394\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243657561\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
U2AF1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1435\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPLICING COACTIVATOR SUBUNIT SRM300; RNA BINDING PROTEIN; AT-RICH ELEMENT BINDING FACTOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0387861\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.159183\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.2436573\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SRRM2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1436\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPLICING FACTOR U2AF 65 KDA SUBUNIT (U2 AUXILIARY FACTOR 65 KDA SUBUNIT) (U2 SNRNP AUXILIARY FACTOR LARGE SUBUNIT) (HU2AF(65)). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.408379\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.67604\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243657073\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
U2AF2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1437\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"RAC-BETA SERINE/THREONINE PROTEIN KINASE (EC 2.7.1.-) (RAC-PK-BETA) (PROTEIN KINASE AKT-2) (PROTEIN KINASE B, BETA) (PKB BETA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0211896\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0870115\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.24352643\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AKT2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1438\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAC-ALPHA SERINE/THREONINE KINASE (EC 2.7.1.-) (RAC-PK-ALPHA) (PROTEIN KINASE B) (PKB) (C-AKT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0218319\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.089649\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.24352642\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AKT1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1439\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.23697\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.973079\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243525962\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NLE1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1440\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"RAC-GAMMA SERINE/THREONINE PROTEIN KINASE (EC 2.7.1.-) (RAC-PK-GAMMA) (PROTEIN KINASE AKT-3) (PROTEIN KINASE B, GAMMA) (PKB GAMMA) (STK-2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0249436\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.102427\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243525633\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AKT3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1441\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.539944\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.21735\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243508693\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
UTP15\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1442\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSDUCIN BETA-LIKE 3; WD-REPEAT PROTEIN SAZD. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.306804\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.26013\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243470118\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TBL3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1443\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0255702\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.105024\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243470064\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
COQ2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1444\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLUTAMYL TRNA SYNTHETASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.16091\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.66093\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.243459973\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
EARS2\vspace{3pt}}\\\cline{1-4}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1445\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLUTAMINYL-TRNA SYNTHETASE (EC 6.1.1.18) (GLUTAMINE--TRNA LIGASE) (GLNRS). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.193092\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.793116\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
QARS\vspace{3pt}}\\\cline{1-4}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1446\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPERMIDINE SYNTHASE (EC 2.5.1.16) (PUTRESCINE AMINOPROPYLTRANSFERASE) (SPDSY). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.032182\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.132186\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
SRM\vspace{3pt}}\\\cline{1-4}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1447\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLYCYL-TRNA SYNTHETASE (EC 6.1.1.14) (GLYCINE--TRNA LIGASE) (GLYRS). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.064364\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.264372\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
GARS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1448\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BASIC PROLINE-RICH PEPTIDE P-E (IB-9). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0700456\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.287741\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243432809\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1449\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SALIVARY PROLINE-RICH PROTEIN PO (ALLELE K) [CONTAINS: PEPTIDE P-D] (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0770791\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.316634\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243432796\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRB4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1450\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROBABLE CALCIUM-TRANSPORTING ATPASE KIAA0703 (EC 3.6.3.8). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0721789\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.296552\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243393739\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP2C2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1451\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UPF0202 PROTEIN KIAA1709. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.06283\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4.367\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.243377605\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NAT10\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/